Molecular Partners AG
MOLN
$3.71
-$0.17-4.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.90% | -7.02% | 40.16% | -32.54% | -45.86% |
| Total Depreciation and Amortization | 7.49% | -11.46% | -1.73% | 9.19% | 38.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.47% | 24.39% | -65.80% | 66.80% | 151.05% |
| Change in Net Operating Assets | -1,016.76% | -154.98% | -88.95% | 249.20% | -338.43% |
| Cash from Operations | -27.71% | -12.49% | 21.87% | 16.41% | -26.45% |
| Capital Expenditure | -- | -348.45% | 66.67% | 76.64% | -221.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -132.48% | 13.20% | -26.80% | -53.63% | 893.76% |
| Cash from Investing | -132.86% | 12.22% | -26.54% | -53.34% | 859.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 1.64% | -0.33% | -0.33% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -98.36% | 6,000.00% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.66% | 1.18% | -28.99% | 12.30% | -101.93% |
| Foreign Exchange rate Adjustments | 129.73% | -294.77% | 94.76% | -1,227.84% | -116.08% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | 308.33% | -- | -- |
| Net Change in Cash | -6,358.40% | -23.33% | -34.34% | -96.24% | 1,010.13% |